Recurrence of hepatitis b-related hepatocellular carcinoma is associated with high viral load at the time of resection

American Journal of Gastroenterology

Volumn 103, Issue 7, 2008, Pages 1663-1673

  Hung, Ivan F N ^a   Poon, Ronnie T P ^a   Lai, Ching Lung ^a   Fung, James ^a   Fan, Sheung Tat ^a   Yuen, Man Fung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; ALPHA FETOPROTEIN;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUMOR DIFFERENTIATION; VIRUS LOAD; AGE; AGED; FOLLOW UP; HEPATITIS B VIRUS; ISOLATION AND PURIFICATION; LIVER TUMOR; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; RISK FACTOR; TUMOR RECURRENCE; VIROLOGY;

AGE FACTORS; AGED; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS; VIRAL LOAD;

EID: 50649117339     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2008.01872.x     Document Type: Article

References (31)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Befeler AS, Di Bisceglie AM. Hepatocellular carcinoma: Diagnosis and treatment. Gastroenterology 2002;122:1609-19.
3. Marrero CR, Marrero JA. Viral hepatitis and hepatocellular carcinoma. Arch Med Res 2007;38:612-20.
4. Gao JD, Shao YF, Xu Y, et al. Tight association of hepa- tocellular carcinoma with HBV infection in North China. Hepatobiliary Pancreat Dis Int 2005;4:46-9.
5. Yuen MF, Tanaka Y, Shinkai N, et al. Risk for hep- atocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels. Gut 2008;57:98-102.
6. Ohata K, Hamasaki K, Toriyama K, et al. High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection. J Gastroenterol Hepatol 2004;19:670-5.
7. Cheung TK, Lai CL, Wong BC, et al. Clinical features, biochemical parameters, and virological profiles of patients with hepatocellular carcinoma in Hong Kong. Aliment Pharmacol Ther 2006;24:573-83.
8. Lin CL, Liu CH, Chen W, et al. Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocel- lular carcinoma. J Gastroenterol Hepatol 2007;22:1098- 103.
9. Lu SN, Wang JH, Liu SL, et al. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma. Cancer 2006;107:2212-22.
10. Chung NS, Kwon OS, Park CH, et al. A comparative cross- sectional study of the development of hepatocellular carcinoma in patients with liver cirrhosis caused by hepatitis B virus, alcohol, or combination of hepatitis B virus and alcohol. Korean J Gastroenterol 2007;49:369-75.
11. Poon RT, Fan ST, Ng IO, et al. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 2000;89:500- 7.
12. Shah SA, Cleary SP, Wei AC, et al. Recurrence after liver resection for hepatocellular carcinoma: Risk factors, treatment, and outcomes. Surgery 2007;141:330-9.
13. Nanashima A, Tanaka K, Yamaguchi H, et al. Fibrosis and inflammatory activity in noncancerous tissue and mi- totic index of cancer tissue in patients with hepatocel- lular carcinoma: Relationship to clinicopathological factors and prognosis after hepatic resection. Dig Dis Sci 2003;48:1517-22.
14. Sugauchi F, Orito E, Ichida T, et al. Epidemiological and virological characteristics of hepatitis B virus genotype B having the recombination with genotype C. Gastroenterol- ogy 2003;124:925-32.
15. Tanaka Y, Mukaide M, Orito E, et al. Specific mutations in enhancer II/core promoter ofhepatitis B virus subgeno- types C1/C2 increase the risk of hepatocellular carcinoma. J Hepatol 2006;45:646-53.
16. Yamamoto J, Kosuge T, Saiura A, et al. Effectiveness of hepatic resection for early-stage hepatocellular carcinoma in cirrhotic patients: Subgroup analysis according to Milan Criteria. Jpn J Clin Oncol 2007;34:287-95.
17. Kubo S, Hirohashi K, Tanaka H, et al. Virologic and biochemical changes and prognosis after liver resection for hepatitis B virus-related hepatocellular carcinoma. Dig Surg 2001;18:26-33.
18. Yeh CN, Lee WC, Jeng LB, et al. Hepatic resection for hepatocellular carcinoma in elderly patients. Hepatogas- troenterology 2004;51:219-23.
19. Zhou L, Rui JA, Wang SB, et al. Clinicopathological features, post-surgical survival and prognostic indicators of elderly patients with hepatocellular carcinoma. Eur J Surg Oncol 2006;32:767-72.
20. Shiratori Y, Shiina S, Imamura M, et al. Characteristic difference of hepatocellular carcinoma between hepatitis Band C-viral infection in Japan. Hepatology 1995;22:1027- 33.
21. Chen JD, Liu CJ, Lee PH, et al. Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinoma. Clin Gastroenterol Hepatol 2004;2:64-71.
22. Kim BW, Kim YB, Wang HJ, et al. Risk factors for immediate post-operative fatal recurrence after curative resection of hepatocellular carinoma. World J Gastroenterol 2006;12:99-104.
23. Jeng KS, Sheen IS, Tsai YC. Does the presence of circulating hepatocellular carcinoma cells indicate a risk ofrecur- rence after resection? Am J Gastroenterol 2004;99:1503-9.
24. Lai EC, You KT, Ng IO, et al. The pathological basis of resection margin for hepatocellular carcinoma. World J Surg 1993;17:786-90.
25. Kubo S, Hirohashi K, Tanaka H, et al. Usefulness ofviral concentration measurement by transcription-mediated amplification and hybridization protection as a prognostic factor for recurrence after resection of hepatitis B virus-related hepatocellular carcinoma. Hepatol Res 2003;25:71-7.
26. Lupberger J, Hildt E. Hepatitis B virus-induced oncogen- esis. World J Gastroenterol 2007;13:74-81.
27. Feitelson MA, Lee J. Hepatitis B virus integration, fragile sites, andhepatocarcinogensis. Cancer Lett 2006;252:157- 70.
28. Colombo M, Sangiovanni A. Etiology, natural history and treatment of hepatocellular carcinoma. Antiviral Res 2003;60:145-50.
29. Pan J, Clayton M, Feitelson MA. Hepatitis B virus X antigen promotes transforming growth factor-beta1 (TGF-beta1) activity by up-regulation of TGF-beta1 and down-regulation of alpha2-macroglobulin. J Gen Virol 2004;85:275-82.
30. Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006;295:65-73.
31. Iloeje UH, Yang HI, Su J, et al. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006;130:678-86.